U.S. Energy Services Stock News

NYSE:YOU
NYSE:YOUSoftware

Clear Secure Mount Sinai Deal Tests Healthcare Potential And Valuation Upside

Clear Secure has partnered with Mount Sinai Health System to roll out its CLEAR1 digital identity platform across one of New York City's largest health systems. The collaboration focuses on improving digital experiences for patients and staff while helping streamline day to day healthcare operations. The move reflects Clear Secure's push beyond travel use cases into healthcare, applying its identity technology in a large scale clinical setting. For investors watching Clear Secure...
NasdaqCM:NAGE
NasdaqCM:NAGEPersonal Products

The Bull Case For Niagen Bioscience (NAGE) Could Change Following Record 2025 Results And Injectable Expansion

Niagen Bioscience recently reported its strongest year to date, with 2025 net sales reaching US$129.4 million, net income of US$17.4 million, and management guiding for 2026 net sales to grow a further 10%–15% year-over-year excluding divested analytical reference standards and services revenue. Alongside this financial progress, the company deepened its intellectual property around nicotinamide riboside injectables and broadened into new categories such as at-home injection kits and...
NYSE:LII
NYSE:LIIBuilding

Lennox Enters Water Heating With Ariston JV As Valuation Stays Steady

Lennox International (NYSE:LII) has entered the North American water heating market through a joint venture with Ariston Group. The partnership is launching a new line of water heaters, adding to Lennox's existing product portfolio. The move expands Lennox's dealer network and allows contractors to offer integrated HVAC and water heating solutions. Lennox International, best known for residential and commercial HVAC systems, is now stepping into water heating, a closely related category...
NasdaqGS:OMDA
NasdaqGS:OMDAHealthcare

Omada Health (OMDA) Is Up 14.4% After GLP-1 Flex Launch and Narrowed 2025 Net Loss

In early March 2026, Omada Health launched its GLP-1 Flex Care program for employer clients and reported fourth-quarter 2025 revenue of US$75.85 million with net income of US$5.16 million, alongside full-year 2025 revenue of US$260.21 million and reduced annual net loss of US$12.78 million. By combining a cash-pay GLP-1 access model that limits employers’ drug spend with improving profitability metrics, Omada is positioning its virtual care platform as both a cost-control and...
NYSE:TPB
NYSE:TPBTobacco

Institutional Split On Turning Point Brands Nicotine Pouch Pivot And Valuation

Large investors have been actively reshaping their positions in Turning Point Brands (NYSE:TPB) following the company’s move toward nicotine pouches. Apis Capital Advisors has raised its stake, while Cannell Capital has cut its holdings, with both changes occurring soon after a strong earnings report. These moves highlight differing views on the shift from legacy products to modern oral nicotine and the role of nicotine pouches in TPB’s future. Turning Point Brands, trading at $91.66, has...
NYSE:DX
NYSE:DXMortgage REITs

New Dynex Capital CFO Appointment Puts Focus On Valuation And Risks

Dynex Capital (NYSE:DX) announced a Chief Financial Officer transition, with Michael Sartori appointed as CFO. Sartori succeeds Robert Colligan, who is departing from the role. The company stated that the transition is not related to its financial reporting or internal controls. For shareholders of Dynex Capital, a mortgage REIT focused on fixed income investments, a CFO change is a meaningful development because it touches funding decisions, balance sheet structure, and risk management...
NYSE:ELAN
NYSE:ELANPharmaceuticals

Is It Time To Reassess Elanco (ELAN) After A 110% One-Year Share Price Surge

If you are wondering whether Elanco Animal Health's current share price lines up with its underlying worth, this article will walk through the key numbers that matter for valuation. The stock last closed at US$23.36, with returns of 3.7% year to date and 109.7% over the past year, which may have changed how investors think about both its growth potential and risk. Recent coverage around Elanco has focused on its position in animal health and investor interest following its share price moves,...
NasdaqGM:APPF
NasdaqGM:APPFSoftware

AppFolio Revenue Mix Shifts Toward High Margin Services And Resident Monetization

AppFolio (NasdaqGM:APPF) reports accelerating revenue growth tied to wider adoption of paid services and fresh income streams. Management highlights stronger free cash flow margins alongside this revenue performance. The company outlines a financial outlook that includes expectations for continued topline and margin expansion into 2026. New direct resident-facing offerings are emerging as a meaningful contributor to the overall business model. AppFolio, which provides software and services...
NasdaqCM:RCAT
NasdaqCM:RCATAerospace & Defense

Red Cat Alliance Expands AI Defense Role Across Air And Maritime

Red Cat Holdings (NasdaqCM:RCAT) has entered an alliance with Allen Control Systems under the Futures Initiative to integrate AI-powered counter-drone and autonomous weapon solutions. The collaboration extends Red Cat’s technology beyond aerial drones into both air and maritime defense domains. The move positions Red Cat as a broader multi-domain defense technology provider, with potential relevance for government and allied contracts. Red Cat Holdings, trading at $15.36, is drawing...
NasdaqGS:PSMT
NasdaqGS:PSMTConsumer Retailing

PriceSmart Expansion To 60 Clubs Tests Rich Valuation And Growth Assumptions

PriceSmart plans to open four new warehouse clubs in 2026. The expansion would bring the total footprint to 60 locations. The announcement highlights a material shift in the company’s future operating scale. For investors watching NasdaqGS:PSMT, the expansion plans land on top of a share price of $145.16 and a long run of positive returns, including 17.7% year to date and 65.1% over the past year. Over three years, the stock is up 125.6%, while the five year return stands at 58.1%. This...
NYSEAM:BATL
NYSEAM:BATLOil and Gas

Battalion Oil (BATL) Is Up 305.1% After US$15 Million Private Placement With New Investor

Battalion Oil Corporation recently completed a private placement with a new institutional investor, raising US$15,000,000 at US$5.50 per share or prefunded warrant, with Roth Capital Partners acting as the sole placement agent. This funding, alongside recent asset sales and increased gas processing capacity, highlights how Battalion Oil is reshaping its balance sheet amid heightened geopolitical risks to global oil supply. With this fresh US$15,000,000 capital injection as a backdrop, we’ll...
NasdaqGS:VICR
NasdaqGS:VICRElectrical

Is It Too Late To Consider Vicor (VICR) After Its 173% One Year Surge?

If you are looking at Vicor and wondering whether the recent price puts the stock on sale or already pricing in a lot of optimism, the valuation picture is the key question to tackle next. Vicor shares last closed at US$162.67, with returns of 173.2% over 1 year, 279.2% over 3 years, 65.1% over 5 years, a 7.0% gain over the past 30 days and a 19.2% decline over the past week. These figures can change how the market weighs its potential and its risks. Recent market attention on Vicor has been...
NYSE:WTRG
NYSE:WTRGWater Utilities

Does Essential Utilities’ Bond-Funded Water Expansion Shift the Risk-Reward Profile for WTRG Investors?

In early March 2026, Essential Utilities, Inc. completed a US$499.34 million fixed-rate senior unsecured bond issuance at 5.125% due 2036 and recently closed its US$18 million acquisition of the Greenville Municipal Water Authority in Pennsylvania. Together with increased institutional interest and planned US$10 million system upgrades, these moves highlight Essential Utilities’ ongoing use of the bond market to fund expansion and long-horizon infrastructure investment in regulated water...
NasdaqGS:MLKN
NasdaqGS:MLKNCommercial Services

MillerKnoll Faces Profitability Strain As Flat Revenue Tests Value Case

MillerKnoll, NasdaqGS:MLKN, is facing sustained profitability challenges alongside flat revenue over the past two years. The company is also seeing declining earnings per share and low cash flow margins, signaling pressure on its core business performance. With shares recently trading at $19.71, these ongoing trends are drawing increased attention from investors focused on longer term fundamentals. MillerKnoll, NasdaqGS:MLKN, is contending with a tougher stretch in which revenue has been...
NasdaqGS:COO
NasdaqGS:COOMedical Equipment

Cooper Companies (COO) Margin Slippage Challenges Bulls After Q1 2026 Earnings

Cooper Companies (COO) opened fiscal Q1 2026 with revenue of US$1.0b and basic EPS of US$0.66, while trailing 12 month EPS stood at US$2.03 on revenue of US$4.2b. The company has seen quarterly revenue move between US$964.7m and US$1.1b over the past year, with basic EPS ranging from US$0.43 to US$0.66. Investors are now weighing these headline numbers against a trailing net margin of 9.7% that has eased from 10.6% a year earlier, putting profitability trends firmly in focus. See our full...
NYSE:GDDY
NYSE:GDDYIT

Is It Time To Reconsider GoDaddy (GDDY) After Recent Share Price Weakness

If you are wondering whether GoDaddy's current share price lines up with its underlying worth, you are not alone. This article is built to help you think that through clearly. GoDaddy shares last closed at US$93.95, with a 7 day return of 7.8%, a 30 day return of 1.8% decline, a year to date return of 20.7% decline, a 1 year return of 46.4% decline, a 3 year return of 29.8% and a 5 year return of 29.7%. Recent moves in the share price have put more attention on how the market is currently...
NasdaqGS:AKTS
NasdaqGS:AKTSBiotechs

Aktis Oncology Fast Track Win Highlights AKY-1189 Potential And Key Risks

Aktis Oncology (NasdaqGS:AKTS) received FDA Fast Track designation for AKY-1189 in advanced urothelial cancer. The designation aims to support faster clinical development and regulatory review for this radiopharmaceutical candidate. The company also provided updates on the ongoing NECTINIUM-2 Phase 1b trial of AKY-1189. Aktis Oncology focuses on radiopharmaceutical therapies, targeting cancers that can be difficult to treat with existing options. For investors watching NasdaqGS:AKTS, the...
NYSE:IHS
NYSE:IHSTelecom

IHS Holding Buyout By MTN Turns Tower Growth Story Into Cash Exit

IHS Holding (NYSE:IHS) has agreed to be acquired by MTN Group in an all cash transaction. The merger agreement has received full approval from the IHS Holding Board. The deal offers shareholders immediate liquidity with a premium to the recent trading price. The announcement comes during a period of challenging market and geopolitical conditions for tower operators. IHS Holding runs telecom tower infrastructure across multiple emerging markets, giving mobile operators shared access to...
NasdaqCM:LMB
NasdaqCM:LMBConstruction

Limbach Relocation To Tampa Highlights Push Into Mission Critical Verticals

Limbach Holdings (NasdaqCM:LMB) is relocating its corporate headquarters to Tampa, Florida in its 125th anniversary year. The company is aligning its senior leadership and a growing share of its workforce around the Tampa area. The move accompanies ongoing acquisitions and a sharpened focus on national vertical markets, including healthcare, data centers, and industrial manufacturing. Limbach Holdings operates as a building systems solutions provider, with services that span mechanical,...
NasdaqGS:TEM
NasdaqGS:TEMLife Sciences

Is Tempus AI (TEM) Pricing Reflect Its AI Healthcare Ambitions After Recent Share Pullback

If you are wondering whether Tempus AI's share price reflects its underlying worth, you are not alone. Many investors are asking the same question as the story around this stock matures. Tempus AI recently closed at US$52.26, with returns of a 1.9% decline over 7 days, a 2.4% decline over 30 days and a 16.2% decline year to date, set against a 6.4% gain over the past year. Recent coverage has focused on Tempus AI's position in applying AI tools to healthcare decision making and how that...
NYSE:ENR
NYSE:ENRHousehold Products

Energizer Holdings Sell Off Puts Dividend Strength And Debt In Focus

Energizer Holdings (NYSE:ENR) is under pressure following a sector wide sell off in consumer staples. The move is linked to rising geopolitical tensions and renewed inflation concerns affecting equity markets. Investors are reassessing near term risk for battery and household product makers as volatility increases. Energizer Holdings, known for its batteries and household products, is getting fresh attention as consumer staples stocks react to macro headlines. With geopolitical tensions in...
NYSE:KR
NYSE:KRConsumer Retailing

Kroger (KR) One Off US$2.8b Loss Puts 0.7% Margin Narrative Under Scrutiny

How Kroger's FY 2026 Numbers Set the Stage Kroger (KR) closed FY 2026 with fourth quarter revenue of US$34.7 billion and EPS of US$1.37, alongside net income of US$861 million as investors weighed the full year picture. Over the past year, revenue in the reported quarters ranged from US$33.7 billion to US$45.1 billion, while quarterly EPS swung between a loss of US$2.02 and a high of US$1.37, with trailing twelve month EPS at US$1.56 reflecting that volatility. With trailing net margins...
NYSE:EQH
NYSE:EQHDiversified Financial

Did Record AUM, Wealth Inflows, and RGA Reinsurance Just Shift Equitable Holdings' (EQH) Investment Narrative?

Equitable Holdings recently reported past full-year 2025 results with record assets under management and administration of US$1.10 trillion, alongside US$8.40 billion in Wealth Management net inflows and a US$2.00 billion capital release from a life reinsurance deal with RGA that cut net mortality exposure by 75%. By hitting its US$200.00 million Wealth Management earnings goal two years early and freeing up significant capital through reinsurance, the company reinforced its emphasis on...
NasdaqGS:BLLN
NasdaqGS:BLLNHealthcare

BillionToOne Market Share Gains Raise Questions On Undervalued BLLN Stock

BillionToOne, listed as NasdaqGS:BLLN, is gaining market share in U.S. prenatal and oncology genetic testing, supported by its Quantitative Counting Template technology. The company’s UNITY prenatal test, which does not require paternal DNA samples, is helping it build a substantial position in the U.S. prenatal screening market. These developments highlight fresh business momentum that could influence how investors view BLLN within the genetic testing space. BillionToOne focuses on blood...